Portfolio company
Healionics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VenoStent
This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.
Artifex
This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.
XS Innovations
This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.
Laminate Medical Technologies
This company develops an external support device to improve fistula success for hospitals and clinicians treating patients requiring dialysis.
Sonavex
This medical technology company develops automated ultrasound devices and bioresorbable markers for dialysis clinics and surgical teams to monitor vascular access and blood flow.
Haermonics
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
VASCULAR THERAPIES
This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.
Proteon Therapeutics
This company develops pharmaceuticals to improve blood flow and vascular access for patients with kidney and vascular diseases.
